• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机模拟研究鉴定 SARS-CoV-2 M 蛋白靶标有潜力的抑制剂

An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M Target.

机构信息

Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.

Department of Pharmacy, Pilani, Birla Institute of Technology & Sciences Pilani Campus, Pilani-333031, India.

出版信息

Med Chem. 2023;19(9):925-938. doi: 10.2174/1573406419666230413112802.

DOI:10.2174/1573406419666230413112802
PMID:37069723
Abstract

BACKGROUND

A limited number of small molecules against SARS-CoV-2 has been discovered since the epidemic commenced in November 2019. The conventional medicinal chemistry approach demands more than a decade of the year of laborious research and development and a substantial financial commitment, which is not achievable in the face of the current epidemic.

OBJECTIVE

This study aims to discover and recognize the most effective and promising small molecules by interacting SARS-CoV-2 M target through computational screening of 39 phytochemicals from five different Ayurvedic medicinal plants.

METHODS

The phytochemicals were downloaded from Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) PubChem, and the SARS-CoV-2 protein (PDB ID: 6LU7; M) was taken from the PDB. The molecular interactions, binding energy, and ADMET properties were analyzed.

RESULTS

The binding affinities were studied using a structure-based drug design of molecular docking, divulging 21 molecules possessing greater to equal affinity towards the target than the reference standard. Molecular docking analysis identified 13 phytochemicals, sennoside-B (-9.5 kcal/mol), isotrilobine (-9.4 kcal/mol), trilobine (-9.0 kcal/mol), serratagenic acid (-8.1 kcal/mol), fistulin (-8.0 kcal/mol), friedelin (-7.9 kcal/mol), oleanolic acid (-7.9 kcal/mol), uncinatone (-7.8 kcal/mol), 3,4-di- O-caffeoylquinic acid (-7.4 kcal/mol), clemaphenol A (-7.3 kcal/mol), pectolinarigenin (-7.2 kcal/mol), leucocyanidin (-7.2 kcal/mol), and 28-acetyl botulin (-7.2 kcal/mol) from ayurvedic medicinal plants phytochemicals possess greater affinity than the reference standard Molnupiravir (-7.0 kcal/mol) against SARS-CoV-2-M.

CONCLUSION

Two molecules, namely sennoside-B, and isotrilobine with low binding energies, were predicted as most promising. Furthermore, we carried out molecular dynamics simulations for the sennoside-B protein complexes based on the docking score. ADMET properties prediction confirmed that the selected docked phytochemicals were optimal. These compounds can be investigated further and utilized as a parent core molecule to create novel lead molecules for preventing COVID-19.

摘要

背景

自 2019 年 11 月疫情爆发以来,已发现了少量针对 SARS-CoV-2 的小分子。传统的药物化学方法需要超过十年的艰苦研发工作和大量的财务投入,而面对当前的疫情,这是无法实现的。

目的

本研究旨在通过对来自五种不同阿育吠陀药用植物的 39 种植物化学物质进行计算机筛选,发现和识别与 SARS-CoV-2 M 靶标相互作用的最有效和最有前途的小分子。

方法

从 Research Collaboratory for Structural Bioinformatics(RCSB)Protein Data Bank(PDB)PubChem 下载植物化学物质,从 PDB 中获取 SARS-CoV-2 蛋白(PDB ID:6LU7;M)。分析分子相互作用、结合能和 ADMET 特性。

结果

使用基于结构的药物设计分子对接研究结合亲和力,揭示了 21 种分子对靶标具有比参考标准更大或相等的亲和力。分子对接分析鉴定了 13 种植物化学物质,番泻苷 B(-9.5 kcal/mol)、异千里光碱(-9.4 kcal/mol)、千里光碱(-9.0 kcal/mol)、蛇麻脂酸(-8.1 kcal/mol)、拳头(-8.0 kcal/mol)、friedelin(-7.9 kcal/mol)、齐墩果酸(-7.9 kcal/mol)、乌头酮(-7.8 kcal/mol)、3,4-二-O-咖啡酰奎宁酸(-7.4 kcal/mol)、香豆素酚 A(-7.3 kcal/mol)、pectolinarigenin(-7.2 kcal/mol)、白藜芦醇(-7.2 kcal/mol)和 28-乙酰 botulin(-7.2 kcal/mol)来自阿育吠陀药用植物的植物化学物质对 SARS-CoV-2-M 的亲和力大于参考标准 Molnupiravir(-7.0 kcal/mol)。

结论

两种分子,即番泻苷 B 和异千里光碱,具有较低的结合能,被预测为最有前途的分子。此外,我们根据对接得分对番泻苷 B 蛋白复合物进行了分子动力学模拟。ADMET 特性预测证实,所选对接的植物化学物质是最佳的。这些化合物可以进一步研究,并用作预防 COVID-19 的新型先导分子的母体核心分子。

相似文献

1
An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M Target.计算机模拟研究鉴定 SARS-CoV-2 M 蛋白靶标有潜力的抑制剂
Med Chem. 2023;19(9):925-938. doi: 10.2174/1573406419666230413112802.
2
Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.从阿育吠陀药用植物中进行计算搜索以寻找潜在的COVID-19药物,以鉴定针对SARS-CoV-2靶点的潜在抑制剂。
Curr Comput Aided Drug Des. 2023;19(1):51-67. doi: 10.2174/1573409919666221117145404.
3
Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.筛选一些具有活性的植物化学成分,以鉴定有希望抑制 SARS-CoV-2 靶点的抑制剂。
Curr Drug Discov Technol. 2024;21(3):73-89. doi: 10.2174/0115701638243222230920051050.
4
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
5
Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).综合虚拟筛选海洋多环胍类生物碱对 SARS-CoV-2(COVID-19)的抗病毒潜力。
Biomolecules. 2021 Mar 19;11(3):460. doi: 10.3390/biom11030460.
6
Virtual Screening of Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme.基于 SARS-CoV-2 主蛋白酶的虚拟筛选潜在抑制剂的植物化学成分
Molecules. 2022 Nov 21;27(22):8103. doi: 10.3390/molecules27228103.
7
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.从天然来源开发针对冠状病毒蛋白酶的有效治疗分子。
Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431.
8
Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M) using molecular docking and deep learning methods.利用分子对接和深度学习方法鉴定药用植物来源的植物化学物质作为 SARS-CoV-2 主蛋白酶(M)的潜在抑制剂。
Comput Biol Med. 2023 May;157:106785. doi: 10.1016/j.compbiomed.2023.106785. Epub 2023 Mar 11.
9
Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M: an approach towards drug repurposing.对含有 HIV 蛋白酶抑制剂的 APNS 与 SARS-CoV-2 M 结合相互作用的分子见解:药物再利用的一种方法。
J Biomol Struct Dyn. 2023 Jun;41(9):3900-3913. doi: 10.1080/07391102.2022.2059008. Epub 2022 Apr 7.
10
Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents.探索泰国药用植物的治疗潜力:用于新型抗 SARS-CoV-2 药物的植物成分的体外筛选和计算机对接。
BMC Complement Med Ther. 2024 Jul 19;24(1):274. doi: 10.1186/s12906-024-04586-z.

引用本文的文献

1
Studies of Phytoconstituents to Identify Potential Inhibitors for ERα Protein of Breast Cancer.研究植物成分以鉴定乳腺癌雌激素受体α蛋白的潜在抑制剂。
Med Chem. 2025;21(2):144-159. doi: 10.2174/0115734064301748240821081206.
2
Identifying Natural Products as Feline Coronavirus M Inhibitors by Structural-Based Virtual Screening and Enzyme-Based Assays.通过基于结构的虚拟筛选和基于酶的分析鉴定天然产物作为猫冠状病毒M蛋白抑制剂
ACS Omega. 2025 Jan 10;10(2):2092-2101. doi: 10.1021/acsomega.4c08601. eCollection 2025 Jan 21.
3
Identification of Potential Inhibitors from Medicinal Plant-based Phytochemicals for the Influential C4 Target of Diabetic Retinopathy by Molecular Docking Studies.
通过分子对接研究从药用植物来源的植物化学物质中鉴定糖尿病视网膜病变的重要C4靶点的潜在抑制剂。
Curr Pharm Des. 2025;31(4):307-319. doi: 10.2174/0113816128297758240723104452.